7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/22/2013

Company Name Symbol %Change
ALLIANCE FIB AFOP
9.31%
SONIC FOUNDR SOFO
7.77%
VELTI PLC OR VELT
7.58%
TRI TECH HOL TRIT
6.62%
A M R CP AAMRQ
4.52%

Christopher & Banks' Weak 2Q Ahead

by Zacks Equity Research

September 26, 2011 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Christopher & Banks Corp. ( CBK - Snapshot Report ) has recently announced a weak outlook for the second quarter of fiscal 2012. Net sales are now expected to be $96.2 million, down 5.0% year over year. Comparable store sales will also decline 8%. Gross margin is expected to be down between 640 bps and 700 bps year over year in second quarter 2012 due to a planned reduction in closing price and increased promotional activity aimed at clearance of slower moving products. Additionally, the pricing action that the company took on the new fall collection was higher than the acceptable range. This resulted in higher inventory on the company’s book.

Adjusted loss is expected in the range 22–24 cents while GAAP loss will range between 37–39 cents after the inclusion of an expected tax provision of approximately $0.1 million. The Zacks Consensus Estimate for second quarter 2012 sales is $97.0 million while the Zacks Consensus Estimate is pegged at a loss of 21 cents.

Inventory pile-up remains a cause of concern for the company. Management expects total inventory to be up 34% year over year to $53.7 million. In-store inventory is expected to increase approximately 13% year over year on a per store basis. However, management remained impressed with the progress of its merchandise assortment, as customers were willing to pay higher prices on select items although enough of the assortment did not reflect these characteristics.

Management is now trying to make adjustments to its merchandise assortment and future pricing strategy to order to encourage sales momentum. On a positive note, Christopher & Banks is expected to end second quarter 2012 with cash, cash equivalents and investments of approximately $95.8 million and no long-term debt. While the Minneapolis-based specialty retailer of women’s clothing is currently reeling under pressure, we believe its solid balance sheet will help the company to see modest results over the long term. As of September 22, 2011, the company operates 773 stores in 46 states.

Christopher & Banks, which competes with peers like Cache Inc. ( CACH - Snapshot Report ) and Foot Locker Inc. ( FL - Snapshot Report ) , is slated to report its second quarter 2012 earnings on October 5, after the closing bell. The stock has outperformed the Zacks Consensus Estimate thrice out of the last four quarters. The earnings surprise ranges from negative 40.00% to a massive 183.33%, with the average being 64.48%. Christopher & Banks currently retains a Zacks #3 Rank, which translates into a short-term Hold rating. We are also maintaining our long-term Neutral recommendation on the stock.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.